#1 Clinical Trials Search in Europe

Exenatide

Exenatide, also known as AC2993 or synthetic exendin-4, is a drug being studied in clinical trials for the treatment of type 2 diabetes mellitus. These trials aim to assess its effects on glucose control, body weight, and overall safety when used alone or in combination with other diabetes medications. The studies involve various dosages and administration methods to determine the optimal use of exenatide in managing diabetes.

Table of Contents

What is Exenatide?

Exenatide is a medication used primarily in the treatment of type 2 diabetes mellitus. It belongs to a class of drugs called GLP-1 receptor agonists (glucagon-like peptide-1 receptor agonists). Exenatide is also known by its brand names Byetta and Bydureon, and in some clinical trials, it’s referred to as AC2993 or synthetic exendin-4[1][2][3].

What Conditions Does Exenatide Treat?

Exenatide is primarily used to treat:

  • Type 2 Diabetes Mellitus: This is the main condition for which exenatide is prescribed. It helps control blood sugar levels in adults with type 2 diabetes[1][2][3].
  • Chronic Kidney Disease: Some studies are investigating its potential benefits in patients with type 4 cardiorenal syndrome, which involves both heart and kidney issues[4].
  • Left Ventricular Diastolic Dysfunction: This is a condition where the heart’s left ventricle doesn’t relax properly between beats. Research is exploring exenatide’s effects on this condition[4].

How Does Exenatide Work?

Exenatide works by mimicking a hormone called GLP-1 (glucagon-like peptide-1) in your body. Here’s how it helps:

  • Stimulates insulin production: It encourages your pancreas to release more insulin when your blood sugar levels are high. Insulin helps move sugar from your blood into your cells[2].
  • Reduces glucagon: Exenatide decreases the amount of glucagon in your body. Glucagon is a hormone that raises blood sugar levels[2].
  • Slows digestion: It can slow down the emptying of your stomach, which helps control how quickly sugar enters your bloodstream after eating[2].
  • Promotes weight loss: Many patients experience weight loss while taking exenatide, which can be beneficial for managing diabetes[3].

How is Exenatide Administered?

Exenatide is administered through subcutaneous injection. This means it’s injected just under the skin, typically in the thigh, abdomen, or upper arm. There are two main forms of exenatide:

  • Immediate-release (Byetta): This is typically injected twice daily, before morning and evening meals[2].
  • Extended-release (Bydureon): This is a long-acting form that is injected once weekly[4].

Dosage Information

The dosage of exenatide can vary depending on the specific formulation and individual patient needs. Here are some general guidelines based on the clinical trials:

  • Immediate-release (Byetta):
    • Starting dose: 5 μg (micrograms) twice daily for 4 weeks
    • Maintenance dose: May be increased to 10 μg twice daily if needed and tolerated[2]
  • Extended-release (Bydureon):
    • Typically 2 mg injected once per week[4]

Always follow your doctor’s instructions regarding dosage, as they may adjust it based on your individual response and needs.

Effectiveness of Exenatide

Clinical trials have shown that exenatide can be effective in managing type 2 diabetes. Its effectiveness is often measured by changes in HbA1c levels, which reflect average blood sugar levels over the past 2-3 months. Some key findings include:

  • Improved blood sugar control: Studies have shown significant reductions in HbA1c levels in patients taking exenatide compared to placebo[3].
  • Weight loss: Many patients experience weight loss while taking exenatide, which can be beneficial for managing diabetes[3].
  • Combination therapy: Exenatide has been shown to be effective when used alone or in combination with other diabetes medications like metformin or sulfonylureas[1][3].

Potential Side Effects

Like all medications, exenatide can cause side effects. Some potential side effects include:

  • Gastrointestinal issues: Nausea, vomiting, and diarrhea are common, especially when first starting the medication[2].
  • Hypoglycemia: When used with certain other diabetes medications, there may be an increased risk of low blood sugar[2].
  • Injection site reactions: Some people may experience redness, itching, or swelling at the injection site[4].

Always discuss potential side effects with your healthcare provider and report any unusual symptoms you experience while taking exenatide.

Ongoing Research

Researchers continue to study exenatide to understand its full potential. Some areas of ongoing research include:

  • Cardiorenal syndrome: Investigating its effects on heart and kidney function in patients with type 4 cardiorenal syndrome[4].
  • Hypoglycemia awareness: Studying whether exenatide can improve awareness of low blood sugar episodes in patients with type 1 diabetes[2].
  • Brown adipose tissue: Exploring its potential effects on brown fat activity and energy expenditure[5].

These ongoing studies may lead to new uses for exenatide or provide more information about its long-term effects and benefits.

Aspect Details
Drug Name Exenatide (AC2993, synthetic exendin-4)
Condition Studied Type 2 Diabetes Mellitus
Administration Subcutaneous injection, typically twice daily
Dosages 2.5 mcg, 5 mcg, 10 mcg
Primary Outcomes Changes in HbA1c, fasting plasma glucose, body weight
Study Duration Varies, up to 52 weeks in some trials
Combination Therapies Studied with metformin and/or sulfonylureas
Special Populations Includes studies on adolescents and different ethnic groups (e.g., South Asians)
Additional Research Effects on brown adipose tissue and energy expenditure

FAQ

  • What is exenatide and how does it work? Exenatide is a synthetic version of a hormone called GLP-1 (glucagon-like peptide-1). It helps control blood sugar levels by stimulating insulin production, reducing glucose production in the liver, and slowing down digestion.
  • How is exenatide administered in these clinical trials? In the trials, exenatide is typically administered through subcutaneous injections, either once or twice daily. The dosages range from 2.5 mcg to 10 mcg, depending on the specific study protocol.
  • What are the main outcomes being measured in these trials? The primary outcomes being measured include changes in HbA1c (a measure of long-term blood sugar control), fasting plasma glucose levels, body weight, and the occurrence of any adverse events.
  • Can exenatide be used with other diabetes medications? Yes, several trials are studying the use of exenatide in combination with other diabetes medications such as metformin and sulfonylureas to see if it provides additional benefits in glucose control.
  • Are there any potential side effects of exenatide being monitored in these trials? While specific side effects are not mentioned in the provided trial information, the studies are monitoring for adverse events, changes in vital signs, ECG results, and laboratory values to assess the overall safety and tolerability of exenatide.

Ongoing Clinical Trials on Exenatide

  • Study on How Exenatide Affects Early Parkinson’s Disease Progression in Patients

    Recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Sweden

  • Study on Using Exenatide PET/CT Imaging for Detecting Paragangliomas in Patients

    Recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study of Drug Combination with Amodiaquine and Potassium Canrenoate Plus Exenatide or Glibenclamide for Patients with Acute Ischemic Stroke

    Not yet recruiting

    2 1 1
    Investigated drugs:
    Greece

  • Evaluation of Long-Term Efficacy and Safety of Tirzepatide Versus Intensified Conventional Care in Early Treatment of Type 2 Diabetes in Adults

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany Italy Romania Slovakia

  • Study on Imaging Beta Cells in Patients with a History of Gestational Diabetes Using Exenatide

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study on Verapamil and Exenatide for Adults with Type 1 Diabetes to Measure Changes in Beta Cell Mass

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Austria France

  • Study on the Effects of Exenatide in Patients with Hypopituitarism and Oxytocin Deficiency

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • HbA1c: Also known as glycosylated hemoglobin, it's a measure of average blood sugar levels over the past 2-3 months. It's used to diagnose diabetes and monitor long-term blood sugar control.
  • Fasting plasma glucose: The level of glucose in the blood after an 8-12 hour fast. It's used to diagnose and monitor diabetes.
  • Metformin: A common oral medication used to treat type 2 diabetes by reducing the amount of glucose produced by the liver and improving insulin sensitivity.
  • Sulfonylurea: A class of drugs used to treat type 2 diabetes by stimulating the pancreas to produce more insulin.
  • Subcutaneous injection: An injection given into the fatty tissue just beneath the skin.
  • Placebo: An inactive substance used in clinical trials to compare the effects of a drug against no treatment.
  • Pharmacokinetics: The study of how a drug is absorbed, distributed, metabolized, and eliminated by the body.
  • Pharmacodynamics: The study of the biochemical and physiological effects of drugs on the body, including their mechanisms of action.
  • Brown Adipose Tissue (BAT): A type of body fat that generates heat by burning calories, potentially playing a role in metabolism and weight control.

References

  1. https://clinicaltrials.gov/study/NCT00044668
  2. https://clinicaltrials.gov/study/NCT02735031
  3. https://clinicaltrials.gov/study/NCT00035984
  4. https://clinicaltrials.gov/study/NCT02251431
  5. https://clinicaltrials.gov/study/NCT03002675